Bing

SEARCH HISTORY

Reuters is reporting that billionaire hedge fund manager John Paulson has bought more than 6 million shares of Allergan, Inc. (AGN), or about a 2% stake, and supports a deal between the Botox maker and Valeant Pharmaceuticals Inc (VRX). Back in April ...
Wall Street Pit · 6/27/2014
According to Yahoo! Finance, at least one analyst has issued a price target for KYTHERA stock at $85.00 per share. If you own the common stock of KYTHERA and purchased your shares before June 17, 2015, if you have information or would like to learn …
4 Traders · 6/18/2015
17.06.15 Tuesday’s most followed in U.S. including Synergy Pharma. Allergan. Kythera. Celgene. Adobe. Qihoo 360. Starbucks. Bob Evans. T-Mobile US. Energen. FedEx 17.06.15 Tuesday’s most followed in U.S. including Synergy Pharma. Allergan.
Finanzen · 6/17/2015
More from Bing News
Things appear to be going pretty smoothly for serial dealmaker Valeant ($VRX) since its failed bid for Allergan ($AGN) in November ... Still, Valeant's New York-listed stock has shot up 94% in the past 12 months--its best rolling 12-month performance ...
FiercePharma · 6/22/2015
June 17, 2015 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of KYTHERA Biopharmaceuticals Inc. KYTH, +0.31% by Allergan plc AGN ... and 20% in new Allergan stock, at a fixed-value of $ ...
Market Watch · 6/17/2015
Investors in Botox maker Allergan (AGN) should have permanent smiles on their faces -- and not because they used the injectable facial treatment. Allergan's stock is up nearly 90% this year thanks to a takeover soap opera. The stock first took off in late ...
CNN Money · ByJesse Solomon andPaul R. La · 12/18/2014
Allergan (NYSE: AGN) and KYTHERA Biopharmaceuticals ... under which Hill-Rom will acquire Welch Allyn for approximately $2.05 billion in cash and stock. The two companies have nearly two centuries of medical device innovation between them and will …
StreetInsider · 6/17/2015
Allergan PLC (NYSE:AGN) gained 0.5 percent to 299.60 after the Botox maker ... after saying its board authorized the repurchase of up to an additional 4 billion in stock on top of the 5.2 billion remaining from previous …
MENAFN · 6/18/2015
interest rate
The list of nine stocks that meet these criteria includes Allergan Inc. (NYSE: AGN), which saw its stock price pop in April on a takeover bid from Valeant Pharmaceuticals Inc. (NYSE: VRX) and activist investor Bill Ackman. By the time Allergan had agreed ...
24/7 Wall ST · 12/18/2014
Actavis has adopted Allergan plc as its new global name and will trade under a new stock symbol, AGN, which was announced at the opening bell at the New York Stock Exchange. The name change was approved by Actavis shareholders on June 5 …
Healio · 6/15/2015

Allergan

Company
Allergan, plc is a global pharmaceutical company focused on developing, manufacturing and commercializing branded …
Allergan, plc is a global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Allergan has a commercial presence across approximately 100 countries. The company has global headquarters in Dublin, Ireland and administrative headquarters in Parsippany-Troy Hills, New Jersey, United States.
Data from: Wikipedia